RTOG 0525: A RANDOMIZED PHASE III TRIAL COMPARING STANDARD ADJUVANT TEMOZOLOMIDE (TMZ) WITH A DOSE-DENSE (DD) SCHEDULE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) Conference

Gilbert, Mark R, Wang, Meihua, Aldape, Ken D et al. (2011). RTOG 0525: A RANDOMIZED PHASE III TRIAL COMPARING STANDARD ADJUVANT TEMOZOLOMIDE (TMZ) WITH A DOSE-DENSE (DD) SCHEDULE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) . NEURO-ONCOLOGY, 13 51-51.

International Collaboration

cited authors

  • Gilbert, Mark R; Wang, Meihua; Aldape, Ken D; Stupp, Roger; Hegi, Monika; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara C; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P

sustainable development goals

authors

publication date

  • November 1, 2011

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

publisher

  • OXFORD UNIV PRESS INC

start page

  • 51

end page

  • 51

volume

  • 13